Related Experiment Videos
Congenital left ventricular diverticula: a rare cause of sudden cardiac death
M E Speechly-Dick1, R M Oliver, G I Slapak
1Department of Cardiology, University College and Middlesex Hospitals, London, UK.
Insights
Congenital left ventricular diverticula, a rare heart condition, can cause sudden cardiac death. This case highlights ventricular fibrillation as a serious complication, emphasizing the need for prompt diagnosis and treatment.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Congenital left ventricular diverticula (CLVD) are rare cardiac malformations.
- CLVD are associated with significant morbidity and mortality, including sudden cardiac death.
- The association between CLVD and ventricular fibrillation (VF) has not been previously reported.
Observation:
- A case of CLVD presenting with ventricular fibrillation is described.
- Diagnosis was established using cardiac catheterization and magnetic resonance imaging (MRI).
- The patient experienced life-threatening arrhythmias and risk of emboli.
Findings:
- This is the first reported instance of ventricular fibrillation in association with congenital left ventricular diverticula.
- Cardiac catheterization and MRI confirmed the diagnosis of CLVD.
- The successful diagnosis and management of this rare condition were achieved.
Implications:
- This case expands the known clinical spectrum of CLVD.
- It underscores the importance of considering CLVD in patients with unexplained ventricular arrhythmias.
- Prompt diagnosis and management with anti-arrhythmic and anticoagulant therapy are crucial for preventing adverse outcomes such as sudden cardiac death and embolic events.
Abstract:
Congenital left ventricular diverticula are a rare cause of sudden cardiac death. We describe the first reported case of ventricular fibrillation in association with congenital diverticula of the heart. The diagnosis of left ventricular diverticula was made by cardiac catheterization and confirmed by magnetic resonance imaging. Treatment was initiated with anti-arrhythmic and anticoagulant drugs to prevent life-threatening arrhythmias and emboli.